Compare AMWD & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMWD | CDNA |
|---|---|---|
| Founded | 1980 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.8M | 1.0B |
| IPO Year | 1995 | 2007 |
| Metric | AMWD | CDNA |
|---|---|---|
| Price | $40.21 | $20.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $59.50 | $28.00 |
| AVG Volume (30 Days) | 120.8K | ★ 780.9K |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $1,709,585,000.00 | $48,324,000.00 |
| Revenue This Year | N/A | $16.01 |
| Revenue Next Year | N/A | $11.31 |
| P/E Ratio | ★ N/A | $431.20 |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $35.51 | $10.96 |
| 52 Week High | $72.16 | $23.24 |
| Indicator | AMWD | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 38.20 | 56.81 |
| Support Level | $37.44 | $15.07 |
| Resistance Level | $42.58 | $21.20 |
| Average True Range (ATR) | 1.76 | 1.67 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 2.25 | 63.26 |
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.